LifeMD, Inc. — Director's Dealing 2021

Feb 3, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2020-12-21

Reporting Person: Roberts Brad Michael (Chief Operating Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Restricted Stock Units	10000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to purchase shares of Common Stock	$		Common Stock, par value $0.001 (200000)		Direct

Footnotes

F1: Pursuant to the terms of the amended and restated employment agreement, by and between Mr. Roberts and the Issuer, on January 8, 2021 (the "Effective Date"), Mr. Roberts was granted: (i) 10,000 restricted stock units of the Company's common stock (the "RSUs") which shall vest on December 21, 2021; and (ii) stock options to purchase up to 200,000 shares of the Company's common stock at an exercise price of $7.50 per share (the "Stock Options"). 35,000 of the Stock Options vested on the Effective Date, with the remaining Stock Options scheduled to vest in equal monthly tranches, based on the passage of time, over the 30 months following the approval of the Effective Date.